Page last updated: 2024-09-03

angiotensin ii, des-phe(8)- and Blood Clot

angiotensin ii, des-phe(8)- has been researched along with Blood Clot in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adams, GN; Bilodeau, ML; Chen, A; Fang, C; Grobe, N; LaRusch, G; Mahdi, F; Morris, M; Nieman, MT; Schmaier, AA; Schmaier, AH; Stavrou, E; Warnock, M; Zhou, Y	1
Buczko, W; Chabielska, E; Kucharewicz, I; Matys, T; Pawlak, R	1

Reviews

1 review(s) available for angiotensin ii, des-phe(8)- and Blood Clot

Article	Year
Angiotensin-(1-7): an active member of the renin-angiotensin system. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2002, Volume: 53, Issue:4 Pt 1 Topics: Angiotensin I; Animals; Cardiovascular Physiological Phenomena; Cell Division; Humans; Kidney; Peptide Fragments; Receptors, Angiotensin; Renin-Angiotensin System; Thrombosis	2002

Other Studies

1 other study(ies) available for angiotensin ii, des-phe(8)- and Blood Clot

Article	Year
Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation. Blood, 2013, Apr-11, Volume: 121, Issue:15 Topics: Angiotensin I; Angiotensin II; Animals; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Cyclic AMP; Cyclic GMP; Epoprostenol; Immunoblotting; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thrombosis; Time Factors	2013

Article

Year

Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.

Blood, 2013, Apr-11, Volume: 121, Issue:15

Topics: Angiotensin I; Angiotensin II; Animals; Bleeding Time; Blood Platelets; Bone Marrow Transplantation; Cyclic AMP; Cyclic GMP; Epoprostenol; Immunoblotting; Mice; Mice, 129 Strain; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 2; Receptor, Bradykinin B2; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Thrombosis; Time Factors

2013